Know Cancer

or
forgot password

Prospective Study To Determine Whether Tissue Scoring Results In Noticeable Marks Following Mohs Micrographic Surgery


Phase 2/Phase 3
18 Years
65 Years
Not Enrolling
Both
Skin Cancer

Thank you

Trial Information

Prospective Study To Determine Whether Tissue Scoring Results In Noticeable Marks Following Mohs Micrographic Surgery


Mohs Micrographic Surgery is a well established method utilizing microscopic margin
controlled excision for treatment of cutaneous malignancies (See Appendix A). It has the
highest cure rate of any of the methods used to treat common cutaneous malignancies and is a
proven safe outpatient procedure. Part of the technique requires marking skin surrounding
the tumor to correspond with tissue that has been removed and divided into pieces for
processing and microscopic examination. Currently there are two established ways of marking
the tissue; lightly scoring it with a scalpel or marking it with a surgical marker. Scoring
tissue is faster, more accurate, and there is no risk of having the marking washed or rubbed
away.


Inclusion Criteria:



- Patients who are able to legally consent to study and are scheduled for Mohs
Micrographic Surgery to remove their malignancies

Exclusion Criteria:

- Patients who are unable to legally consent themselves, do not wish to participate or
who are not scheduled to undergo Mohs Micrographic Surgery.

- Children, those with mental handicaps, pregnant women, prisoners, those with
cognitive impairments, and life-threatening diseases will be excluded.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator)

Outcome Measure:

The goal of the study is to determine if there are any noticeable differences in outcomes between patients who have their skin scored and those who have their skin marked with a surgical marking pen

Outcome Time Frame:

2 Years

Safety Issue:

No

Principal Investigator

Daniel Eisen, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of California, Davis

Authority:

United States: Institutional Review Board

Study ID:

200513516-1

NCT ID:

NCT00367042

Start Date:

July 2005

Completion Date:

July 2008

Related Keywords:

  • Skin Cancer
  • Skin Neoplasms

Name

Location
UC Davis Medical Center Department of Dermatology Sacramento, California  95816